Correction: Chang-Wei-Qing Combined with PD-1 Inhibitor Alleviates Colitis-Associated Colorectal Tumorigenesis by Modulating the Gut Microbiota and Restoring Intestinal Barrier
Junkai Wen, Shunyun Wang, Kexiang Sun, Haoyue Wang, Zeting Yuan, Wanli Deng · 2026
Read Correction: Chang-Wei-Qing Combined with PD-1 Inhibitor Alleviates Colitis-Associated Colorectal Tumorigenesis by Modulating the Gut Microbiota and Restoring Intestinal Barrier by Junkai Wen, Shunyun Wang, Kexiang Sun, Haoyue Wang, Zeting Yuan, Wanli Deng (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13401785.txt.
Description
Junkai Wen and co-authors are named in a 2026 correction in Biological Procedures Online for their 2024 paper on combining the herbal formula Chang-Wei-Qing with a PD-1 inhibitor. It was tested against colitis-linked colorectal tumours in mice. The correction concerns duplicated panels inside Figure 6 of the original article.
The authors explain that two magnified immunohistochemistry sections in the control group, staining for the barrier proteins ZO-1 and occludin, were inadvertently identical. Separately, magnified images for the group receiving faecal transplant plus the herbal formula and anti-PD-1 treatment, staining for ZO-1 and claudin, were mistakenly duplicated as well. Those barrier proteins matter because the paper's claim rests on restoring the intestinal barrier. A corrected figure is supplied with the notice, and the original article has been updated.
Catalog record
| CREATOR | Junkai Wen, Shunyun Wang, Kexiang Sun, Haoyue Wang, Zeting Yuan, Wanli Deng |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 817 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |